Position in RGNX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$280,730
New position
Shares Held
33,500
first reported quarter
Ownership
0.065%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Militia Capital Management LLC holds $8,743,234 across 9 Biotechnology names. RGNX ranks #7 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,000 | $2,317,920 | |
| 2 | ABVX |
Abivax S.A.
|
17,000 | $1,892,950 | |
| 3 | QURE |
uniQure N.V.
|
94,200 | $1,540,170 | |
| 4 | MRNA |
Moderna, Inc.
|
23,001 | $1,168,450 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
29,700 | $882,387 | |
| 6 | INCY |
Incyte Corp
|
3,600 | $338,832 | |
| 7 | RGNX |
REGENXBIO Inc.
This page
|
33,500 | $280,730 | |
| 8 | TSHA |
Taysha Gene Therapies, Inc.
|
46,500 | $207,855 |
All Filings in RGNX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $280,730 | 33,500 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||